ASCO GI Conference Coverage
Filter News By:
Featured Articles
(2020 GI Cancers Symposium) Jan 24, 2020 - Positive findings from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study cohorts on the potential benefit of various molecularly targeted drugs in patients with advanced colorectal cancer will be presented at the 2020 Gastrointestinal Cancers Symposium, taking place January...
Read Article
(2020 GI Cancers Symposium) Jan 21, 2020 - A blood-based screening test using cell-free DNA to identify methylation signals of hard-to-detect gastrointestinal (GI) cancers that could potentially help detect cancer at earlier stages will be presented 2020 Gastrointestinal Cancers Symposium, taking place January 23-25 in San Francisco,...
Read Article
Latest Articles
February 19, 2020
January 27, 2020
January 27, 2020
January 27, 2020
January 27, 2020
January 27, 2020
January 27, 2020
January 27, 2020
View More
News Commentary
There is no ASCO GI Conference Coverage commentary.

OBR Blog
There are no ASCO GI Conference Coverage blog entries.

OBR Tweets

Feb 20
H. Jack West, MD: The results with atezolizumab in this highly enriched subset echo the findings with pembrolizumab… https://t.co/KbOYjNqeHc

Feb 19
Howard S. Hochster, MD: Another "swing and a miss" in pancreatic cancer. Despite numerous trial of chemotherapy pl… https://t.co/mAuyJZE4fa

Feb 18
William McGivney, PhD: Every once in a while, in my columns, I mention that Rick Pazdur, MD of the FDA NEEDS to be… https://t.co/SgpegJSMWB

Feb 17
Nizar Tannir, MD, of @MDAndersonNews describes the 4 year follow up study of nivolumab + ipilimumab in RCC patients… https://t.co/RY6WXLDL1N

Feb 17
Bradley McGregor, MD @BradMcG04, of @DanaFarber on impressions of phase I/II study of oral HIF-2 α inhibitor MK-648… https://t.co/EPvkjmtsb4

Feb 17
David Quinn, MD, of @KeckMedUSC on impressions of phase I/II study of oral HIF-2 α inhibitor MK-6482 in patients wi… https://t.co/rBvAje1it1

Feb 17
Scott Tawaga, MD, of @WeillCornell on promising PSMA products in development for prostate cancer treatment #GU20 https://t.co/BLfI32lWzS

Feb 17
Tian Zhang, MD, MHS @TiansterZhang, of @DukeCancer elaborates on the PEDIGREE clinical study in advanced renal cell… https://t.co/kgdQPTsquK

Feb 17
Bradley McGregor, MD @BradMcG04, of @DanaFarber describes whether biomarkers will help guide treatment in advanced… https://t.co/2uejg888Ui

Feb 17
Michael Atkins, MD, of @LombardiCancer on follow up investigation of Checkmate 025 in renal cell carcinoma patients… https://t.co/2dyPZwc8dF